Loading clinical trials...
Loading clinical trials...
A Randomized, Active-controlled Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex
Conditions
Interventions
Sulbactam
Durlobactam
+2 more
Locations
90
United States
Entasis Research Site
Chicago, Illinois, United States
Entasis Research Site
Shreveport, Louisiana, United States
Entasis Research Site
Cincinnati, Ohio, United States
Entasis Research Site
Memphis, Tennessee, United States
Entasis Research Site
Houston, Texas, United States
Entasis Research Site
Brest, Belarus
Start Date
September 5, 2019
Primary Completion Date
July 26, 2021
Completion Date
July 26, 2021
Last Updated
February 1, 2023
Lead Sponsor
Entasis Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions